John A Taraszka
Inventor
Stats
- 2 US patents issued
- 10 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 2 US Patents Issued
- 10 US Applications Filed
- 150 Total Citation Count
- Dec 1, 2021 Most Recent Filing
- Jan 30, 2015 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| NOVARTIS AG | 2
3 | 2015
2017 |
| CHILDREN'S MEDICAL CENTER CORPORATION | 2
3 | 2015
2017 |
| DANA-FARBER CANCER INSTITUTE, INC. | 2
3 | 2015
2017 |
Inventor Addresses
| Address | Duration |
|---|---|
| Arlington, MA, US | Mar 19, 20 - Oct 31, 23 |
| Cambridge, MA, US | Aug 06, 15 - Jun 16, 22 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 10 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 4 |
| C07K: | PEPTIDES | 9 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 11802152 | 2023 | Methods of treating FGF21-associated disorders | 0 |
| 2022/0185,883 | 2022 | METHOD OF DETECTING TIM-3 USING ANTIBODY MOLECULES TO TIM-3 | 4 |
| 2022/0162,300 | 2022 | METHODS OF TREATING FGF21-ASSOCIATED DISORDERS | 0 |
| 2022/0133,889 | 2022 | COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO TIM-3 | 3 |
| 11236159 | 2022 | Methods of treating FGF21-associated disorders | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.